UCLH Head and Neck Centre, London, UK.
Lasers Med Sci. 2012 Jan;27(1):169-79. doi: 10.1007/s10103-011-0916-z. Epub 2011 Apr 15.
The use of the CO(2) laser in the management of oral dysplastic lesions has become a more common practice. Very few studies have evaluated recurrence, residual disease malignant transformation, and overall outcome in patients undergoing such a procedure. In this prospective study, a total of 123 oral dysplastic lesions from 77 consecutive patients were treated with the CO(2) laser (resection and/or ablation). The average age was 58 ± 4.8 years. The patients' recovery was uneventful and no complications were reported. Comparisons with the clinical and histopathological features and rate of recurrence as well as malignant transformation were made. The patients were followed-up for a mean of 6.4 years, and biopsies taken in case of changes suggestive of malignant development. Homogenous leukoplakias were identified in 31 patients, non-homogenous leukoplakias in 34 patients, whereas 12 patients had erythroplakias. Ex- and life-long smokers formed 88.3% of the recruited patients. While people who currently smoke and drink formed 55.8% of the cohort. Erythroplakias were solely identified in heavy life-long smokers. The most common identified primary anatomical locations were the lateral border of tongue, floor of mouth, and buccal mucosa. Moderate dysplasia was identified in 42 patients while 18 patients had severe dysplasia. Laser resection margins in selected cases (68 patients) were clear in 53 and showed mild-moderate dysplasia in the involved margins. The rate of recurrence had no significant association with the location but the severity of epithelial dysplasia. The rate of first recurrence after laser surgery was approximately 19.5%. Malignant transformation was observed in eight patients (10.4%), in the tongue and the floor of mouth. Recurrence and malignant transformation was mainly identified in erythroplakias and non-homogenous leukoplakias. Laser resection/ablation is recommended for oral dysplasia to prevent not only recurrence and malignant transformation but also postoperative oral dysfunction encountered by other conventional modalities.
二氧化碳激光在口腔上皮异型性病变的治疗中已得到广泛应用。但仅有少数研究评估了此类治疗后的复发、残留病变恶性转化及总体结局。在这项前瞻性研究中,共对 77 例连续患者的 123 处口腔上皮异型性病变采用 CO2 激光(切除和/或消融)进行治疗。患者的平均年龄为 58 ± 4.8 岁。患者恢复顺利,未出现任何并发症。对患者的临床和组织病理学特征、复发率和恶性转化率进行了比较。所有患者的平均随访时间为 6.4 年,对疑似恶性进展的患者进行了活检。31 例患者表现为均质型白斑,34 例患者表现为非均质型白斑,12 例患者为红斑。招募的患者中,有 88.3%为长期吸烟者,55.8%为当前吸烟和饮酒者。只有重度长期吸烟者中存在红斑。最常见的病变部位为舌侧缘、口底和颊黏膜。42 例患者存在中度异型增生,18 例患者存在重度异型增生。在选择的病例(68 例)中,激光切除边缘清晰 53 例,边缘显示轻度-中度异型增生。复发率与病变部位无显著相关性,但与上皮异型增生的严重程度相关。激光手术后的首次复发率约为 19.5%。8 例(10.4%)患者发生恶性转化,病变部位位于舌和口底。复发和恶性转化主要见于红斑和非均质型白斑。为预防复发和恶性转化,以及其他传统方法治疗后出现的口腔功能障碍,推荐对口腔上皮异型性病变采用激光切除/消融。